Search This Blog

Monday, June 6, 2011

Biomedical Advanced Research and Development Authority (BARDA) Exercises Options With Cangene Corporation (CC:CNJ) Worth US$61 Million Under Botulism Antitoxin Supply Contract


BioSpace Jun 6 2011 2:39PM GMT


No comments:

Post a Comment